Login or Register
Welcome , Settings |  Logout
Tags: US | DOJ | AstraZeneca

AG: Drug Maker Astrazeneca to Pay $520 Million

Tuesday, 27 Apr 2010 02:08 PM

 

Share:
More . . .
A    A   |
   Email Us   |
   Print   |

Attorney General Eric Holder says the federal government has reached a $520 million settlement with pharmaceutical manufacturer AstraZeneca, resolving allegations surrounding the company's antipsychotic drug Seroquel.

The case involves AstraZeneca promoting Seroquel for so-called "off-label" uses that are not approved by federal drug regulators, including insomnia and psychiatric conditions besides schizophrenia and bipolar disorder.

© Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Share:
More . . .
   Email Us   |
   Print   |
Around the Web
Join the Newsmax community.
Register to share your comments with the community. Already a member? Login
Note: Comments from readers do not necessarily reflect the viewpoint of Newsmax Media. While we attempt to review comments, if you see an inappropriate comment you can block it by rolling over the comment, clicking the down arrow and selecting "Flag As Inappropriate."
blog comments powered by Disqus
 
Email:
Country
Zip Code:
 
Hot Topics
Top Stories
Around the Web
You May Also Like

US Threatens to Boost Syria Rebels if Assad Won't Talk Peace

Thursday, 23 May 2013 03:04 AM

Washington threatened Wednesday to increase support for Syria's rebels if President Bashar al-Assad refuses to discuss a . . .

UN Report: Iran Rapidly Expanding Nuclear-Weapon Technology

Thursday, 23 May 2013 02:45 AM

The U.N. atomic agency Wednesday detailed rapid Iranian progress in two programs that the West fears are geared toward m . . .

Boehner: ‘Arrogance of Power’ Rampant in Obama White House

Thursday, 23 May 2013 00:12 AM

The current scandals facing President Barack Obama reflect an arrogance of power at the White House, House Speaker Joh . . .

 
 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved